Showing 1561-1570 of 2527 results for "".
- Vichy Laboratories Launches New 48 Hour Moisturizerhttps://modernaesthetics.com/news/vichy-laboratories-launches-new-48-hour-moisturizer/2473644/
- New Deadline: Allergan Aesthetics, University Lab Partners Launch Golden Passport Pitch Competition to Accelerate Aesthetics Start-Upshttps://modernaesthetics.com/news/news-you-can-use-allergan-aesthetics-university-lab-partners-launch-golden-passport-pitch-competition-to-accelerate-aesthetics-start-ups-1/2473512/University Lab Partners (ULP) and Allergan Aesthetics are launching the Golden Passport pitch competition for aesthetic startups. The Golden Passport provides the winner with a lab bench for one year and opportunities to engage with industry mentors including scientific and business lea
- Perfect Corp.’s AI-Powered Live Skin Analysis Now Analyzes 14 Skin Concernshttps://modernaesthetics.com/news/perfect-corps-ai-powered-live-skin-analysis-now-analyzes-14-skin-concerns/2473486/
- Sientra Announces First Shipment of Viality Fat Transfer System; New Preliminary Datahttps://modernaesthetics.com/news/sientra-launches-viality-fat-transfer-system/2473374/Sientra announced that it has begun commercial shipping of its Viality with AuraClens fat transfer system. The company also announced the release of preliminary results from its ongoing, multicenter, long-term volume retention clinical study with Viality. These results show over 80% vol
- Cosmetic Physician Partners Launches Network of Physician-led Medical Aesthetics Clinics in UShttps://modernaesthetics.com/news/cosmetic-physician-partners-launches-network-of-physician-led-medical-aesthetics-clinics-in-us/2473334/Cosmetic Physician Partners Inc. ("CPP") is pleased to announce its official launch in the US with the closing of its 10th medical aesthetics clinic. Led by Dr. A. Jay Burns, Dr. Joel L. Cohen, Matt and Kathy Taranto and Dan Schacter, CPP is a partnership designed to provide physician o
- FDA Nod for Sientra’s Low Plus Profile Projection Breast Implanthttps://modernaesthetics.com/news/fda-nod-for-sientras-low-plus-profile-projection-breast-implant-1/2473263/The U.S. Food and Drug Administration (FDA) approved Sientra’s Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction. This product will be commercially available for board-certi
- Bryant Wong Named Sciton’s first CFOhttps://modernaesthetics.com/news/bryant-wong-named-scitons-first-cfo/2473259/Bryant Wong is Sciton’s first Chief Financial Officer, effective immediately. The announcement was made at Sciton's 25th Anniversary celebration. The year 2022 exemplifies Sciton's ongoing commitment to quality and improvement, with recognition such as 2022 Company of the
- Revance News: FDA Accepts BLA Resubmission for DaxibotulinumtoxinAhttps://modernaesthetics.com/news/revance-news-fda-accepts-bla-resubmission-for-daxibotulinumtoxina/2473223/The U.S. Food and Drug Administration (FDA) accepted Revance’s Biologics License Application (BLA) resubmission for DaxibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines. The FDA designated the BLA as a Class 2 resubmission, which has a six-mont
- Cynosure Launches Potenza™ RF Microneedling System with New Fusion Tip™ in Canadahttps://modernaesthetics.com/news/cynosure-launches-potenza-rf-microneedling-system-with-new-fusion-tip-in-canada/2473149/Health Canada has cleared Cynosure’s Potenza™ radiofrequency (RF) microneedling system, offering clinicians versatility and personalized treatments for patients with the system's one-of-a-kind Fusion
- Sciton Rolls Out New Ad Campaignhttps://modernaesthetics.com/news/sciton-rolls-out-new-ad-campaign/2473022/